elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55205941-D2584A00-1B32-4B46-AA59-4702B09B3109
Q55205941-D2584A00-1B32-4B46-AA59-4702B09B3109
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55205941-D2584A00-1B32-4B46-AA59-4702B09B3109
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia.
P478
Q55205941-D2584A00-1B32-4B46-AA59-4702B09B3109
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55205941-D2584A00-1B32-4B46-AA59-4702B09B3109
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
373bd9960f60e8f8b613af692ee27e821000b5ba
P478
9
http://www.w3.org/2001/XMLSchema#string